About
Gerard Cunningham is an Operating Partner at Adjuvant Capital with 25 years of experience in the vaccine industry, global health partnerships, and consulting. He previously led the new vaccine planning function at Merck and spent over three years at the Bill & Melinda Gates Foundation supporting HIV, TB, and malaria programs, negotiating vaccine access partnerships and conducting technical and supplier diligence. He has also served as a Senior Advisor to the Global Health Investment Fund since 2012 and holds engineering degrees from Cambridge University and an MBA from the University of Michigan.
Invests in
BiotechDigital HealthImpact & Social Good
Experience
- Adjuvant CapitalOperating Partnercurrent2020 — presentNew York City Metropolitan Area
- Innovations for Global HealthFounder & Principalcurrent2013 — presentPennsylvania
- MerckExecutive Director, Strategic Planning - Emerging Markets2012 — 2013New Jersey USA
- Bill & Melinda Gates FoundationSenior Program Officer - Vaccine Delivery2008 — 2012Greater Seattle Area
- Merck Vaccine DivisionSenior Marketing Director2005 — 2008
- MerckDirector of Business Development2001 — 2002
- International Finance CorporationProject Manager1993
Skills & more
Strategy65Leadership16Strategic Planning19Negotiation1Emerging Markets11Business Strategy39Product Development19Vaccines40Business Development19Infectious Diseases5Healthcare4Mergers & Acquisitions1
+12 more
MarketingStrategic CommunicationsSegmentationManufacturingInternational BusinessProduct LaunchBiotechnologyExecutive ManagementMarket ResearchStrategic PartnershipsStart-upsCommercializationFrom Gerard's professional profile.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Glenn Rockman
Co-Founder and Partner at Adjuvant Capital
Jim Robinson
Senior Advisor at Adjuvant Capital
Frequently asked questions
- Who is Gerard Cunningham?
- Gerard Cunningham is an Operating Partner at Adjuvant Capital with 25 years of experience in the vaccine industry, global health partnerships, and consulting. He previously led the new vaccine planning function at Merck and spent over three years at the Bill & Melinda Gates Foundation supporting HIV, TB, and malaria programs, negotiating vaccine access partnerships and conducting technical and supplier diligence. He has also served as a Senior Advisor to the Global Health Investment Fund since 2012 and holds engineering degrees from Cambridge University and an MBA from the University of Michigan.
- Where does Gerard Cunningham work?
- Gerard Cunningham is Operating Partner at Adjuvant Capital.
- What does Gerard Cunningham invest in?
- Gerard Cunningham invests in Biotech, Digital Health, Impact & Social Good.
- Where did Gerard Cunningham go to school?
- Gerard Cunningham studied at University of Cambridge (M. Eng., Manufacturing Engineering); University of Cambridge (M. A., Engineering); University of Michigan - Stephen M. Ross School of Business (MBA, International Marketing Strategy).
Same school
Also attended University of Cambridge896
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 890 more
Also attended University of Michigan - Stephen M. Ross School of Business280
Alexandra FarmerPrincipal at Intel Capital, North AmericaTige SavageCo-founder at RevolutionWendy XiaoPartner at NorthzoneRob LawrenceSenior Finance Associate at GreycroftHyun KooPartner at March Capital PartnersRichard GuVice President at March Capital Partners
+ 274 more
Also attended Università di Siena7
Annalisa D'AndreaVenture Partner at Longwood FundDr. Leopold von Schlenk-BarnsdorfAdvisor in Value Creation at AuxxoIsabella Oline JensenAssociate at The Footprint FirmFrancesca NataliResearch Angel at META GroupDenita AhmetspahicIntern, Operations & Ecosystem Support at XPRENEURSNiko HemsScout at LvlUp Ventures
+ 1 more
Shared employers
Also worked at Merck106
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 100 more
Also worked at Bill & Melinda Gates Foundation56
Bill GatesCo-founder of Microsoft; Chair of the Gates FoundationGülsah WilkeInvestor at DN CapitalRobert PaullCo-Founder and Venture Partner at Lux CapitalKarl Ilias AuerspergInvestment Analyst at C5 CapitalJulie WroblewskiCo-Founder & Managing Partner at Magnify VenturesArunan SkandarajahExecutives in Residence at GENERAL INCEPTION
+ 50 more
Also worked at International Finance Corporation97
Hark AhluwaliaAssociate at RevolutionSofia DahouneInvestor at DaphniKavita GuptaSpecial Advisor at Buckhill CapitalKanika MayarPartner, Investment & ESG Officer at Vertex Ventures Sea Management Pte. Ltd.Gary KhoengPartner, Investment at Vertex Ventures Sea Management Pte. Ltd.Paul AselVenture Partner at NGP Capital
+ 91 more















.png)



























:format(webp)/f/174198/3860x2650/2526f5efbb/steel-blue-kanika.png)
:format(webp)/f/174198/3860x2650/d2b57ecbc2/steel-blue-gary.png)
